Home » Topics » BioWorld Science

BioWorld Science
RSS

New use for Uriach's rupatadine

Oct. 11, 1996

Gene therapy reduces the side effects of chemotherapy

Oct. 11, 1996

New strategy for reducing doxorubicin toxicity

Oct. 11, 1996

First photodynamic therapy approved in the U.S.

Oct. 11, 1996

Clinical trial program for anticancer HER-2/neu inhibitor

Oct. 11, 1996

SuperGen acquires rights to Warner-Lambert anticancer drug

Oct. 11, 1996

Kanebo reports antitumor agent with a novel mechanism of action

Oct. 11, 1996

Japanese researchers report new antimetastatic agents

Oct. 11, 1996

MMP inhibitors from Otsuka

Oct. 11, 1996

DuPont Merck describes bisnaphthalimide anticancer drugs

Oct. 11, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...